Katie Melder, Jess C Mace, Garret Choby, Joao Paulo Almeida, Pierre-Olivier Champagne, Erik Chan, Jeremy Ciporen, Mark B Chaskes, Juan Fernandez-Miranda, Nicholas K Fung, Paul Gardner, Peter Hwang, Keven Seung Yong Ji, Aristotelis Kalyvas, Keonho A Kong, Chirag Patel, Zara Patel, Maria Peris Celda, Carlos D Pinheiro-Neto, Carl Snyderman, Brian D Thorp, Jamie J Van Gompel, Georgios Zenonos, Nathan T Zwagerman, Olabisi Sanusi, Eric W Wang, Mathew Geltzeiler
BACKGROUND: With modern treatment paradigms, olfactory neuroblastoma (ONB) has favorable overall survival (OS); however, the incidence of recurrence remains high. The primary aims of this study were to delineate the prognosis of recurrence of ONB and explore how recurrence subsites are associated with OS, disease-specific survival (DSS), and further recurrence. METHODS: A retrospective chart review of ONB cases from nine academic centers between 2005 and 2021 was completed...
April 3, 2024: International Forum of Allergy & Rhinology